Peer-reviewedCC BY 4.0Frontiers in Oncology30 Sep 2026

Editorial: Artificial intelligence and anti-cancer drugs: advancing discovery, personalization, and precision oncology

Mohamed El-Shazly^1,2
Neeraj Kumar³
Sumit Sheoran⁴

4 affiliations

¹Pharmacognosy Department, Faculty of Pharmacy, Ain Shams University
²Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University
³Feinberg School of Medicine, Northwestern University
⁴Babasaheb Bhimrao Ambedkar University

Open at source PDF DOI Cite

Artificial intelligence and anti-cancer drugs: advancing discovery, personalization, and precision oncology
Faizan ul Haque Nagrami, Pahchan Shukla, Ruchi Yadav +1
Frontiers in Oncology13 Oct 2026Peer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
Editorial: Artificial intelligence in genomic analysis
João Carlos Setubal, André Carlos Ponce de Leon Ferreira de Carvalho
Frontiers in Bioinformatics6 Nov 2026Peer-reviewedCC BYFull textMolecular biology & gene regulation General medicineDOAJ
Editorial: Revolutionizing obstetric and pediatric pharmacology through artificial intelligence and digital health innovations
Jeffrey S. Barrett, Catherine M. Sherwin, Samuel L. SewardJr
Frontiers in Pharmacology28 Oct 2026Peer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsCrossref
Editorial: Decoding cancer complexity with artificial intelligence and molecular level studies: informatics-driven approaches for therapeutic innovation
Chandrabose Selvaraj, Krishnendu Bera, Senthilkumar Krishnamoorthi +1
Frontiers in Oncology28 Oct 2026Peer-reviewedCC BY 4.0Full textOncologyCrossref
Advancing Genitourinary Cancer Surgery: The Role of Artificial Intelligence and Robotics
Stamatios N. Katsimperis, Νικόλαος Κωστακόπουλος, Themistoklis Ch. Bellos +5
Journal of Clinical Medicine17 May 2026Peer-reviewedCC BY14 citedEpidemiology & public healthOpenAlex

Cite

BibTeX RIS

BibTeX

@article{elshazly2026editorial,
  title = {{Editorial: Artificial intelligence and anti-cancer drugs: advancing discovery, personalization, and precision oncology}},
  author = {Mohamed El-Shazly and Neeraj Kumar and Sumit Sheoran},
  journal = {Frontiers in Oncology},
  year = {2026},
  month = sep,
  doi = {10.3389/fonc.2026.1988629},
  url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.1988629/full},
  note = {CC BY 4.0},
}

RIS

TY  - JOUR
TI  - Editorial: Artificial intelligence and anti-cancer drugs: advancing discovery, personalization, and precision oncology
AU  - Mohamed El-Shazly
AU  - Neeraj Kumar
AU  - Sumit Sheoran
PY  - 2026
DA  - 2026/09/30
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2026.1988629
UR  - https://www.frontiersin.org/articles/10.3389/fonc.2026.1988629/full
SN  - 2234-943X
ER  -

Related

Cite